Announcement

Collapse
No announcement yet.

StemCells, Inc. Receives FDA Authorization of IND for Spinal Cord Injury

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    StemCells, Inc. Receives FDA Authorization of IND for Spinal Cord Injury

    NEWARK, Calif., Oct. 2, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that the U.S. Food and Drug Administration (FDA) has authorized the Company's Investigational New Drug (IND) application for clinical testing of the Company's proprietary HuCNS-SC® human neural stem cells as a treatment for spinal cord injury. As a first action under this IND, the Company is working to open U.S. sites for its Phase I/II clinical trial for chronic spinal cord injury, which is currently underway in Switzerland and Canada.

    #2
    Oh very nice! I did not know they were planning to do this in the US also. PICK ME PICK ME!

    Comment


      #3
      This is some good stuff right here! I read about this before on here, there are some good videos on this if anyone wants to check it out - http://inspiredsciforum.com/thread/3...-cord-injuries

      Comment

      Working...
      X